HTB homepage • Conference reports • Articles by subject • Subscribe 9 February 2009 Contents Antiretrovirals Maraviroc safety label changes included with US traditional approval US approval of paediatric abacavir EMEA supports extension of D:A:D study until at least 2012 and the new remit to include non-AIDS cancers and kidney disease Applications to approve non-refrigerated ritonavir submitted to EMEA and FDA PK and drug interactions Elvitegravir with tipranavir/ritonavir or darunavir/ritonavir Serum bilirubin increases when PEG-interferon and ribavirin are used with atazanavir Drug interactions with integrase inhibitors Drug interactions between efavirenz and itraconazole Effect on tacrolimus when switching from nelfinavir to fosamprenavir HTB homepage • Conference reports • Articles by subject • Subscribe
